GBIO Relative Valuation
GBIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GBIO is overvalued; if below, it's undervalued.
Historical Valuation
Generation Bio Co (GBIO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.13. The fair price of Generation Bio Co (GBIO) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：5.23
Fair
-0.72
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Generation Bio Co. (GBIO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -0.90. The thresholds are as follows: Strongly Undervalued below -7.94, Undervalued between -7.94 and -4.42, Fairly Valued between 2.62 and -4.42, Overvalued between 2.62 and 6.14, and Strongly Overvalued above 6.14. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.40
EV/EBIT
Generation Bio Co. (GBIO) has a current EV/EBIT of 0.40. The 5-year average EV/EBIT is -2.13. The thresholds are as follows: Strongly Undervalued below -10.62, Undervalued between -10.62 and -6.38, Fairly Valued between 2.11 and -6.38, Overvalued between 2.11 and 6.35, and Strongly Overvalued above 6.35. The current Forward EV/EBIT of 0.40 falls within the Historic Trend Line -Fairly Valued range.
54.21
PS
Generation Bio Co. (GBIO) has a current PS of 54.21. The 5-year average PS is 99.02. The thresholds are as follows: Strongly Undervalued below -217.52, Undervalued between -217.52 and -59.25, Fairly Valued between 257.30 and -59.25, Overvalued between 257.30 and 415.57, and Strongly Overvalued above 415.57. The current Forward PS of 54.21 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
Generation Bio Co. (GBIO) has a current P/OCF of 0.00. The 5-year average P/OCF is -77.53. The thresholds are as follows: Strongly Undervalued below -713.38, Undervalued between -713.38 and -395.46, Fairly Valued between 240.40 and -395.46, Overvalued between 240.40 and 558.33, and Strongly Overvalued above 558.33. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Generation Bio Co. (GBIO) has a current P/FCF of 0.00. The 5-year average P/FCF is 41.37. The thresholds are as follows: Strongly Undervalued below -319.96, Undervalued between -319.96 and -139.30, Fairly Valued between 222.03 and -139.30, Overvalued between 222.03 and 402.69, and Strongly Overvalued above 402.69. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Generation Bio Co (GBIO) has a current Price-to-Book (P/B) ratio of 0.70. Compared to its 3-year average P/B ratio of 0.93 , the current P/B ratio is approximately -24.79% higher. Relative to its 5-year average P/B ratio of 1.56, the current P/B ratio is about -55.44% higher. Generation Bio Co (GBIO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -117.18%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -77.17% , the current FCF yield is about -100.00% lower.
0.70
P/B
Median3y
0.93
Median5y
1.56
-325.59
FCF Yield
Median3y
-117.18
Median5y
-77.17
Competitors Valuation Multiple
The average P/S ratio for GBIO's competitors is 0.00, providing a benchmark for relative valuation. Generation Bio Co Corp (GBIO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -78.90%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GBIO decreased by 50.75% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -202.71 to -346.30.
The secondary factor is the P/E Change, contributed -42.69%to the performance.
Overall, the performance of GBIO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is Generation Bio Co (GBIO) currently overvalued or undervalued?
What is Generation Bio Co (GBIO) fair value?
How does GBIO's valuation metrics compare to the industry average?
What is the current P/B ratio for Generation Bio Co (GBIO) as of Dec 05 2025?
What is the current FCF Yield for Generation Bio Co (GBIO) as of Dec 05 2025?
What is the current Forward P/E ratio for Generation Bio Co (GBIO) as of Dec 05 2025?